GEOSPACE TECHNOLOGIES CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data GEOSPACE TECHNOLOGIES CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	62.1	73.7	75.7	95.8	87.8	94.9	89.3	125	136	111
Cost of revenue	81.4	94.4	64.8	64.4	64.4	78.6	71.2	72.8	83	77.9
Gross profit	-19.4	-20.7	11	31.4	23.4	16.3	18	51.7	52.6	32.9
Research and development	13.9	13.8	10.8	15.5	16.6	14.8	18.1	15.9	16.3	18.9
Selling, general and administrative	21.5	20.2	19.9	23.6	23.1	21.9	23.5	26	26.6	29.8
Operating expenses	36.1	33.6	31.7				41.2	41.7	45.5	48.8
Operating income	-55.5	-54.3	-20.7	1.03	-18	-16.9	-23.1	11.3	7.12	-11.3
Interest expense	0.03	0.04	0.34	0.1	0.04		0.07	0.13	0.19	0.17
Interest income	0.38	0.65	1.08	1.31	1.1	1.44	0.98	0.54	1.56	2.54
Other non-operating income	0.18	0.22	0.95	1.24	1.45	3.39	0.45	1.24	-13.6	1.95
Pre-tax income	-55.3	-54.1	-19.8	2.27	-16.6	-13.5	-22.7	12.6	-6.46	-9.34
Income tax	-9.36	2.68	-0.58	2.42	2.65	0.58	0.17	0.36	0.11	0.39
Net income	-46	-56.8	-19.2	-0.15	-19.2	-14.1	-22.9	12.2	-6.58	-9.72
EBITDA	-50.1	-49.1	-6.33	20.4	5.65	3.91	-3.58	27.6	21.9	-1.14
EPS, basic	-3.52	-4.32	-1.45	-0.01	-1.42	-1.05	-1.76	0.93	-0.50	-0.76
EPS, diluted	-3.52	-4.32	-1.45	-0.01	-1.42	-1.05	-1.76	0.92	-0.50	-0.76
Shares, basic (weighted)	13	13.1	13.3	13.4	13.5	13.4	13	13.1	13.2	12.8
Shares, diluted (weighted)	13	13.1	13.3	13.4	13.5	13.4	13	13.2	13.2	12.8

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	10.3	15.1	11.9	18.9	32.7	14.1	16.1	18.8	6.9	26.3
Short-term investments	27.5	36.1	25.5	0	0	9.5	0.89	14.9	30.2	0
Receivables	15.4	9.44	14.3	24.2	13.6	12.2	12.7	20.2	14.6	12.7
Inventory	30.8	20.8	18.8	23.9	16.9	16.2	20	18.4	26.2	30.9
Other current assets	1.83	1.62	1.86	1.01	0.95	2.06	2.08	2.25	2.31	3.25
Total current assets	101	86.4	76.7	71.2	64.9	60	60	75.8	89.4	88.5
Property, plant and equipment	44.7	37.4	33.6	31.5	29.9	30	26.6	24	23.2	23.2
Lease right-of-use assets					0.1	1.19	0.96	0.71	0.46	0.92
Goodwill			5.01	5.01	4.34	5.07	0.74	0.74	0.74	1.26
Intangible assets			10.1	10.1	8.33	7.25	5.57	4.81	1.65	5.16
Other non-current assets	0.08	0.63	0.21	0.18		0.46	0.51	0.49	0.3	0.54
Total assets	255	206	199	202	187	164	135	153	152	153
Accounts payable	2.12	2.6	4.11	4.05	1.59	6.39	5.6	6.66	8	10.4
Accrued liabilities	7.85	6.34	6.83	6.37
Deferred revenue	0.17	1.57	3.75	0		0	0	0.7	0	0
Total current liabilities	10.3	10.5	14.7	13.2	10.3	15.2	12.6	19.8	17.2	24.4
Lease liabilities						1.01	0.77	0.51	0.34	0.55
Other non-current liabilities						0.03
Total liabilities	10.3	10.5	22.5	23.2	25.9	21.5	13.4	20.3	17.6	27.5
Total debt							0	0	0	0
Paid-in capital	78	83.7	86.1	88.7	91	92.9	94.7	96	97.3	98.8
Retained earnings	182	126	106	106	86.6	72.5	49.7	61.9	55.3	45.6
Treasury stock						-6.81	-7.5	-7.5	-13.9	-14.5
Other comprehensive income	-15.9	-14.2	-15.6	-15.8	-16.7	-16.3	-15.3	-17.8	-4.26	-4.54
Shareholders' equity	244	195	177	179	161	142	122	133	135	126
Total equity	244	195	177	179	161	142	122	133	135	126
Total liabilities and equity	255	206	199	202	187	164	135	153	152	153
Shares outstanding	13.3	13.4	13.6	13.6	13.7	13	13	13.2	12.7	12.8

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-46	-56.8	-19.2	-0.15	-19.2	-14.1	-22.9	12.2	-6.58	-9.72
Depreciation and amortization	5.39	5.24	14.4	19.3	23.7	20.8	19.6	16.2	14.8	10.1
Stock-based compensation	5.22	5.73	2.32	2.33	2.31	1.97	1.73	1.37	1.3	1.51
Deferred income tax	4.21	-0.03	-0.02	0.02	0.18	0	-0.02	-0	0.02	-0.03
Change in receivables						-1.05	1.05
Change in inventory	5.19	2.96	-7.82	-1.87	0.01	-7.67	-2.36	-11	-11	-7.57
Cash from operations	-1.7	10.1	-10.4	5.63	18.1	-7.17	-10	15.6	-9.08	-22.2
Capital expenditures	-1.87	-1.18	-1.72	-1.94	-2.92	-3.19	-1.13	-3.96	-3.86	-7.97
Acquisitions			-4.35	-1.82		-1.35			0	-1.75
Purchases of investments	-25.8	-19.2	-17.9			-12.5	-0.45	-24.8	-32.1	0
Sales and maturities of investments						2.07
Cash from investing	-10.2	-5.46	7.78	1.56	-4.05	-3.32	14.1	-11.9	3.82	42.7
Stock issued		0.05	0.06	0.22
Share buybacks						-6.81	-0.7	0	-6.39	-0.62
Cash from financing		0.05	0.06	0.22	-0.08	-8.23	-1.71	-0.53	-6.39	-1.01
Exchange rate effect	-0.15	0.15	-0.6
Net change in cash	-12.1	4.83	-3.16	6.99	13.8	-18.6	2.04	2.69	-11.9	19.4
Free cash flow	-3.56	8.91	-12.1	3.69	15.2	-10.4	-11.2	11.6	-12.9	-30.2
Interest paid	0.03	0.04	0.34	0.1	0.04
Income taxes paid			-0.65	2.4	2.53	0.55	0.17	0.15	0.16	0.41

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $4.99 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	8.0%	Gross profit / revenue.
Operating margin	-44.7%	Operating income / revenue.
EBITDA margin	-33.3%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-42.7%	Pre-tax income / revenue.
Net margin	-43.1%	Net income / revenue.
FCF margin	-40.2%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	-34.2%	Cash from operations / revenue.
Return on equity (ROE)	-41.4%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-31.6%	Net income / average total assets.
Return on invested capital (ROIC)	-34.9%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	19.2%	Research and development expense / revenue.
SG&A / revenue	33.1%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.4%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	5.9%	Capital expenditures / revenue.
D&A / revenue	11.3%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-18.3%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	7.5%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	4.8%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-37.4%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	22.2%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	7.0%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-258.6%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	-105.2%	EBITDA vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	-6.8%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	1.0%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-4.9%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	0.6%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	4.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-3.9%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-2.7%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.5%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-1.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.44x	Current assets / current liabilities.
Quick ratio	0.72x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.10x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.00x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	0.0%	Total debt / total assets.
Liabilities / assets	23.5%	Total liabilities / total assets.
Net debt	-$2.8M	Total debt - cash - short-term investments. Negative means more cash than debt.
Interest coverage	-540x	Operating income / interest expense.
Working capital	$40.6M	Current assets - current liabilities.
Goodwill and intangibles / assets	4.8%	(Goodwill + intangible assets) / total assets.
Tangible book value	$89.7M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.73x	Revenue / average total assets.
Fixed asset turnover	4.04x	Revenue / average property, plant and equipment.
Inventory turnover	2.14x	Cost of revenue / average inventory.
Days inventory	171 days	365 x average inventory / cost of revenue.
Receivables turnover	5.25x	Revenue / average receivables.
Days sales outstanding	69 days	365 x average receivables / revenue.
Days payables	27 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	213 days	Days inventory + days sales outstanding - days payables.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$3.06	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$7.10	Revenue / diluted weighted shares.
FCF per share	-$2.85	Free cash flow / diluted weighted shares.
Operating cash flow per share	-$2.43	Cash from operations / diluted weighted shares.
Book value per share	$7.40	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$6.94	Tangible book value / shares outstanding.
Cash per share	$0.22	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$64.5M	Share price x shares outstanding.
Enterprise value	$61.7M	Market cap + total debt - cash - short-term investments.
P/S	0.70x	Market cap / revenue.
P/B	0.67x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	0.72x	Market cap / tangible book value, when positive.
EV/Sales	0.67x	Enterprise value / revenue.
FCF yield	-57.2%	Free cash flow / market cap.
Earnings yield	-61.3%	Net income / market cap (the inverse of P/E).
Shareholder yield	0.0%	(Dividends paid + share buybacks) / market cap.

What was GEOSPACE TECHNOLOGIES CORP's revenue in fiscal 2025?

GEOSPACE TECHNOLOGIES CORP reported revenue of $110.8M for fiscal 2025, 18.3% lower than the year before.

Was GEOSPACE TECHNOLOGIES CORP profitable in fiscal 2025?

No. It reported a net loss of $9.7M.

How much free cash flow did GEOSPACE TECHNOLOGIES CORP generate in fiscal 2025?

Cash from operations of $22.2M minus capital expenditures of $8.0M left free cash flow of -$30.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to GEOSPACE TECHNOLOGIES CORP